We recommend upgrading to the latest version of Microsoft Edge, Google Chrome or Firefox.
Keyword Search:
Test name:
Manual search:
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
NUMBER
ALL
Collect sample just before next dose (trough sample).
NOTE: date,time and amount of last dose must be provided on the request form for result interpretation.
A recent study demonstrated that trough (sample taken just before the next dose) imatinib plasma concentrations were associated with cytogenetic and molecular response in CML. A patient with trough imatinib plasma concentration >1000 ng/ml is 8 times more likely to experience a therapeutic effect compared with patients who have concentrations below this effect target. Furthermore,GIST patients with a trough imatinib plasma concentration <1100 ug/L had lower rates of clinical benifit and faster time to progression. A target for toxicity has not been defined;however,fluid retension,rash,myalgia and anaemia apper to be common at higher imatinib concentrations.
Suggested target for effect in CML is >1000 ug/L
Suggested target for effect in GIST is >1100 ug/L
Toxicity: monitor patient carefully if trough imatinib plasma concentration exceeds 2000 ug/L
Spin,aliquot plasma and freeze.
Frozen sample to be packed by IATA trained personal.
L6, Xavier Building, Victoria Street
Adminisration login
Language Services